Industry leaders want the Indian government to undertake an entire impact and vulnerability study to identify the risk associated with importing...
AstraZeneca Pharma India Limited has received the authorization from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import and market Osimertinib Tablets 40 mg & 80 mg....
In terms of using these medical devices, India imports almost 80 to 85 percent of them; hence, the government and the private sector are prompted towards the idea...
In a rapidly evolving Indian Pharmaceutical market, the growing demand for Obesity and diabetes drugs market is witnessing a huge heap through the continuous innovations by the leading companies. Notably, Danish pharm firm Novo Nordisk has announced
Sun Pharmaceutical Industries has introduced Fexuclue in India, which comprises Fexuprazan tablets (40mg) to treat...
While the Raksha Mantri acknowledged AMC's initiatives of adopting Artificial Intelligence (AI) and carrying out research into advanced technologies, he focused on the requirement of keeping up with evolving practices to bring about a new wave of
A “next-generation” delivery system has been launched by Abbott to streamline the electrode implantation process for its Proclaim DRG neurostimulation system.
The Indian medical devices industry is facing a major challenge as the US imposes a 26% tariff on exports, impacting a sector striving to replicate the success of India’s pharmaceutical industry. With India’s medical device exports to the US valued a
In India's medical device industry, the Gujarat government's recent plan to impose a separate pricing system for drug-eluting stents (DES) has sparked controversy. The new regulation sets the price of stents that have been approved by the US Food....
The 'reciprocal tariff' plans of US President Donald Trump do not cover pharmaceuticals, thus, emphasizing the significance of...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")